Aclasta

DRUG2 trials

Sponsors

Wuerzburg University Hospital, Mel Shiuann-Sheng Lee

Conditions

Bone Marrow EdemaFunctional OutcomesPrevention of BMD Loss After THRSerum Markers of Bone Turnover

Phase 3

Assessment of Efficacy of Zoledronic Acid in the Treatment of Bone Marrow Edema Syndrome

CompletedNCT01348269

Wuerzburg University HospitalBone Marrow Edema

Start: 2011-05-31End: 2015-08-26Updated: 2024-08-13

Prevention of Periprosthetic Bone Loss After Total Hip Replacement by Annual Bisphosphonate Therapy

CompletedNCT02838121

Mel Shiuann-Sheng LeeFunctional Outcomes, Prevention of BMD Loss After THR, Serum Markers of Bone Turnover

Start: 2009-12-31End: 2016-06-30Updated: 2016-07-20

Related Papers

Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial.

2017-05-2224 citations